Celularity Inc. vs IGC Pharma, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- IGC Pharma, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Oct 26, 2026 for IGC Pharma, Inc.).
- Celularity Inc. had more revenue: $27 M in the year to December 2025 against $1 M for IGC Pharma, Inc. in the year to March 2025.
- Both made a net loss: $92 M for Celularity Inc. and $7 M for IGC Pharma, Inc.
- Celularity Inc. keeps more of each dollar of sales: a net margin of -345.5% against -560.6% for IGC Pharma, Inc.
Market cap history
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Celularity Inc. CELU · #23,307 in the world | IGC Pharma, Inc. IGC · #23,120 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $28 M | $29 M |
| Revenue | $27 M | $1 M |
| Net income | $-92 M | $-7 M▲ best |
| Employees | 288 | — |
| Valuation | ||
| Price to sales | 1.5× | 24.9× |
| Price to book | — | 3.9× |
| Free cash flow yield | -23.8% | -16.8%▲ best |
| Profitability | ||
| Gross margin | 24.4% | — |
| Operating margin | -230.9% | — |
| Net margin | -345.5% | — |
| Growth | ||
| Revenue growth | -51.0% | — |
| Revenue growth, 3 years a year | 13.9% | — |
| Financial strength | ||
| Debt to equity | — | 0.0× |
| Altman Z-score zone | distress | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Celularity Inc. or IGC Pharma, Inc.?
IGC Pharma, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Oct 26, 2026 for IGC Pharma, Inc.).
Which makes more money, Celularity Inc. or IGC Pharma, Inc.?
Celularity Inc. had more revenue: $27 M in the year to December 2025 against $1 M for IGC Pharma, Inc. in the year to March 2025. Both made a net loss: $92 M for Celularity Inc. and $7 M for IGC Pharma, Inc.
Which is more profitable, Celularity Inc. or IGC Pharma, Inc.?
Celularity Inc. keeps more of each dollar of sales: a net margin of -345.5% against -560.6% for IGC Pharma, Inc.
More about Celularity Inc.
More about IGC Pharma, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.